Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications.

Doss MX, Sachinidis A. · 2019

Read Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. by Doss MX, Sachinidis A. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6562607.txt.

Description

Doss and Sachinidis take stock of induced pluripotent stem cells a decade into the field, writing in Cells. Reprogrammed from a patient's own skin or blood cells, iPSCs can become almost any cell type. They have exposed the cellular mechanics of many single-gene diseases, powered drug screens and safety tests, and grown into organoids and organs-on-chips. The first trials of iPSC-derived cell products are under way.

Yet the review's stress falls on what still blocks the clinic. Turning lab promise into safe, standard, reproducible therapy runs into stubborn problems of cell quality, consistency and risk that the field has not solved. The authors map those challenges and what must change before regenerative medicine can rely on these cells at scale.

Catalog record

CREATORDoss MX, Sachinidis A.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6562607

Browse the full library · About the Tower of Babel